Ulrich-Merzenich Gudrun, Zeitler Heike, Panek Darius, Bokemeyer Dirk, Vetter Hans
Medical Policlinic of the Rheinische, Friedrich-Wilhelms-University of Bonn, Wilhelmstr. 35-37 53111 Bonn, Germany.
Eur J Nutr. 2007 Mar;46(2):87-94. doi: 10.1007/s00394-006-0636-5.
Epidemiological, secondary prevention and small interventional trials suggest a preventive role of vitamin C for cardiovascular diseases (CAD), especially through improving endothelial dysfunction. Large primary prevention trials failed to confirm this. Mechanistic studies may contribute to resolve this discrepancy.
We examined whether vitamin C activates mitogen-activated protein kinases (MAPK) in human umbilical cord venous endothelial cells (HUVECs) and whether reactive oxygen species (ROS) play a role in this process.
Subconfluent quiescent HUVECs were incubated with vitamin C alone or in combination with catalase (CAT) and/or hydrogenperoxide (H2O2). Intracellular MAPK were determined by Western blot, proliferation by cell count and DNA-synthesis by [3H]-thymidine-uptake.
HUVECs were incubated with vitamin C (60 microM) for 5-60 min or for 20 min (30-90 microM). A dose-dependent phosphorylation of extracellular signal-regulated-kinases (ERKs)-1 and -2 with a maximum of phosphorylation at 15-20 min was observed and inhibitable by MEK1/2-inhibitor U0126 (5-10 microM). Vitamin C (60 microM) stimulated phosphorylation of ERK5, but not of p38 and c-Jun, demonstrating a different MAPK-activation pattern compared to H2O2. Vitamin C (60 microM) induced proliferation and a dose-dependent [3H]-thymidine-uptake (30-120 microM) within 20 h. CAT (0.3 U/ml) did neither suppress the vitamin C induced [3H]-thymidine-uptake nor ERK1/2-phosphorylation. CAT (0.3 U/ml), but not vitamin C (60 microM) abrogated the inhibitory effects of H2O2 (100 microM) on [3H]-thymidine-uptake.
Physiological vitamin C-concentrations promote proliferation of subconfluent ECs by activating an ERK1/2 controlled pathway. Targeting MAPK by vitamin C may improve, besides antioxidant mechanisms, endothelial dysfunction by promoting a fast regeneration of the endothelium after tissue injury, particularly required during secondary prevention and early development.
流行病学、二级预防及小型干预试验提示维生素C对心血管疾病(CAD)具有预防作用,尤其是通过改善内皮功能障碍发挥作用。大型一级预防试验未能证实这一点。机制研究可能有助于解决这一差异。
我们研究了维生素C是否能激活人脐静脉内皮细胞(HUVECs)中的丝裂原活化蛋白激酶(MAPK),以及活性氧(ROS)在此过程中是否发挥作用。
将未融合的静止HUVECs单独用维生素C孵育,或与过氧化氢酶(CAT)和/或过氧化氢(H2O2)联合孵育。通过蛋白质免疫印迹法测定细胞内MAPK,通过细胞计数测定细胞增殖,通过[3H] - 胸腺嘧啶核苷摄取测定DNA合成。
将HUVECs用维生素C(60μM)孵育5 - 60分钟或20分钟(30 - 90μM)。观察到细胞外信号调节激酶(ERKs)-1和-2呈剂量依赖性磷酸化,在15 - 20分钟时磷酸化程度最高,且可被MEK1/2抑制剂U0126(5 - 10μM)抑制。维生素C(60μM)刺激了ERK5的磷酸化,但未刺激p38和c-Jun的磷酸化,与H2O2相比显示出不同的MAPK激活模式。维生素C(60μM)在20小时内诱导细胞增殖和剂量依赖性的[3H] - 胸腺嘧啶核苷摄取(30 - 120μM)。CAT(0.3 U/ml)既未抑制维生素C诱导的[3H] - 胸腺嘧啶核苷摄取,也未抑制ERK1/2磷酸化。CAT(0.3 U/ml)而非维生素C(60μM)消除了H2O2(100μM)对[3H] - 胸腺嘧啶核苷摄取的抑制作用。
生理浓度的维生素C通过激活ERK1/2控制的途径促进未融合内皮细胞的增殖。除抗氧化机制外,维生素C靶向MAPK可能通过促进组织损伤后内皮的快速再生来改善内皮功能障碍,这在二级预防和早期发育过程中尤为必要。